New Toad Venom Compound Synthesized for Clinical Use: 5-MeO-DMT Succinate
Leading scientists continue to remove roadblocks by developing methods for synthesizing psychedelic compounds for further research.
Leading scientists continue to remove roadblocks by developing methods for synthesizing psychedelic compounds for further research.
The Mental Organs Hypothesis reconsiders the relationship between 5-HT2 receptors and the qualitative effects of psychedelics.
This compound exhibits reduced cardiotoxicity, psychoplastogen characteristics, and potential therapeutic effects in animal models.
This study is the first of its kind to suggest that psilocybin enhances emotional empathy but does not affect moral behavior.
Researchers at the forefront of psychedelic science put forth their arguments in this important debate.
Changes in brain functioning, new synthesis methods, and psychotherapy dominate this year’s most-cited psilocybin papers.
This study provides meaningful access to some lesser-known magic mushroom compounds and conducts biological testing on them for the first time.
Interestingly, changes in migraine frequency were not correlated with the intensity of the acute psychotropic effects.
This influential study advances the understanding of magic mushroom physiology and helps answer several fundamental questions.
A recent study shows DMT reduces the cellular stress caused by a stroke and speeds up recovery time in rats. These findings highlight the expanding therapeutic potential of DMT regarding neurological disorders.
Psychedelic Science Review is working to bring cutting-edge science in the field of psychedelics to the public in the most accessible, thorough and accurate way possible. Join our communities on Facebook, Twitter, LinkedIn and Instagram and share our content with your network to help us bring scientifically-backed information about psychedelics to the world.
NEW! Shop the PSR Supporter Store to show your support for psychedelic science.